News, Analysis & Insights on Nutrition, Supplements, and Health
A recent literature review observed that via the gut-brain axis, anthocyanins and their gut-derived metabolites may exhibit a protective effect on the nervous system to neurodegenerative diseases.
The report unpacks what’s in store for dietary supplements and natural products, underscoring how consumer needs will change over the coming year.
Editor's Spotlight
Consumers’ psychological relationship with food is about to transform on a grand scale, thanks to the proliferation of wearable technology and the building ‘glucose revolution’, according to an industry expert.
The deadline for entries to the 2023 NutraIngredients Awards, initially set for today (Jan 23rd), has been extended by two weeks, with the final deadline moved to Feb 6th.
Acetate and butyrate – compounds derived from the gut microbiota – may lower blood pressure in untreated hypertensives, says a new study from Australia.
From the state of the market to the impact of inflation, and from regulatory initiatives like mandatory product listing to equality and diversity in the industry, the NutraIngredients-USA’s Business Leaders Forum will dig deep into a range of industry...
Mibelle Biochemistry has its sights set on sports nutrition with a new haskap berry powder marketed as endurance and performance booster.
Paid for and content provided by PharmaNutra Spa
Eating disorders are a worldwide problem today because of unhealthy habits and lifestyles that have taken hold in today’s society in recent decades.
Paid for and content provided by PharmaNutra Spa
Scientific studies have shown a close correlation between magnesium deficiency in the blood (hypomagnesemia) and the presence of type 2 diabetes mellitus.
The consumption of black tea may lower the risk of ovarian cancer, according to Chinese researchers, although no significant correlation with endometrial cancer and cervical cancer was found.
Suntory has shed more light on its plans for its personalised nutrition services and products in Japan following a US$3.06m investment in UK start-up Remedy Health.